No difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study Nenhuma diferença na evolução da hanseníase entre os esquemas terapêuticos de 12 versus 24 doses: um estudo preliminar

No difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study Nenhuma diferença na evolução da hanseníase entre os esquemas terapêuticos de 12 versus 24 doses: um estudo preliminar

A comparative study was performed on the initial and final bacillary indexes of 213 multibacillary leprosy patients who received 12 doses (Group 1: 128 patients) or 24 doses (Group 2: 85 patients) of multidrug therapy (MDT/WHO) to measure the effectiveness of the two regimens. All patients were eval...

Full description

Bibliographic Details
Main Authors: Anna Maria Sales, Paulo Chagastelles Sabroza, José Augusto da Costa Nery, Nádia Cristina Dupprè, Euzenir Nunes Sarno
Format: Article
Language:English
Published: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz 2007-04-01
Series:Cadernos de Saúde Pública
Subjects:
Hanseníase
Quimioterapia
Estudo Comparativo
Leprosy
Drug Therapy
Comparative Study
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2007000400009

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2007000400009

Similar Items